Khulna University of Engineering & Technology
Central Library

Normal view MARC view ISBD view

Pediatric drug development [electronic resource] : concepts and applications / [edited by] Andrew E. Mulberg, Dianne Murphy, Julia Dunne, Lisa L. Mathis.

Contributor(s): Mulberg, Andrew E [editor of compilation.] | Murphy, M. Dianne [editor of compilation.] | Dunne, Julia, 1954- [editor of compilation.] | Mathis, Lisa L [editor of compilation.].
Material type: materialTypeLabelBookPublisher: Chichester, West Sussex, UK : Wiley Blackwell, 2013Edition: Second edition.Description: 1 online resource.Content type: text Media type: computer Carrier type: online resourceISBN: 9781118312056 ( ePub); 1118312058 ( ePub); 9781118312063 (MobiPocket); 1118312066 (MobiPocket); 9781118312131 (Adobe PDF); 1118312139 (Adobe PDF); 9781118312087; 1118312082.Subject(s): Pediatric pharmacology | Drug development | MEDICAL -- Drug Guides | MEDICAL -- Nursing -- Pharmacology | MEDICAL -- Pharmacology | MEDICAL -- Pharmacy | Drug development | Pediatric pharmacology | Child | Drug Evaluation -- methods | Age Factors | Clinical Trials as Topic -- standards | Drug Evaluation -- ethics | Drug Evaluation -- standardsGenre/Form: Electronic books.Additional physical formats: Print version:: Pediatric drug developmentDDC classification: 615/.190083 Online resources: Wiley Online Library Summary: Pediatric Drug Development, Second Edition, encompasses the new regulatory initiatives across EU, US and ROW designed to encourage improved access to safe and effective medicines for children. It includes new developments in biomarkers and surrogate endpoints, developmental pharmacology and other novel aspects of pediatric drug development.
Tags from this library: No tags from this library for this title. Log in to add tags.
No physical items for this record

Includes bibliographical references and index.

Description based on print version record and CIP data provided by publisher.

Pediatric Drug Development, Second Edition, encompasses the new regulatory initiatives across EU, US and ROW designed to encourage improved access to safe and effective medicines for children. It includes new developments in biomarkers and surrogate endpoints, developmental pharmacology and other novel aspects of pediatric drug development.

There are no comments for this item.

Log in to your account to post a comment.


Khulna University of Engineering & Technology
Funded by: HEQEP, UGC, Bangladesh